{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:03:44Z","timestamp":1756310624425,"version":"3.32.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.msard.2021.103425","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T07:28:58Z","timestamp":1637738938000},"page":"103425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children"],"prefix":"10.1016","volume":"57","author":[{"given":"Liang","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2021.103425_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9451","key":"10.1016\/j.msard.2021.103425_bib0002","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.msard.2021.103425_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2021.103425_bib0004","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2021.103425_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2021.103425_bib0006","doi-asserted-by":"crossref","first-page":"55","DOI":"10.20452\/pamw.1499","article-title":"Autoimmune thyroid diseases and nonorganspecific autoimmunity","volume":"122","author":"Lazurova","year":"2012","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"6280","key":"10.1016\/j.msard.2021.103425_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/346183a0","article-title":"T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis","volume":"346","author":"Ota","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.msard.2021.103425_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2016.04.039","article-title":"Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders","volume":"366","author":"Wang","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2021.103425_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2015.02.014","article-title":"Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders","volume":"281","author":"Li","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2021.103425_bib35","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/cphy.c140035","article-title":"Role of the Thyroid System in Myelination and Neural Connectivity. Compr Physiol","volume":"5","author":"Calz\u00e0","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.msard.2021.103425_bib0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.msard.2017.11.004","article-title":"Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: a cohort of Latin American patients","volume":"19","author":"Carnero Contentti","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2021.103425_bib0012","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1352458519845109","article-title":"Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder","volume":"26","author":"Savoldi","year":"2020","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2021.103425_bib0013","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4103\/1673-5374.193243","article-title":"Higher frequency of brain abnormalities in neuromyelitis optica spectrum disorder patients without primary Sjogren's syndrome","volume":"11","author":"Gu","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.msard.2021.103425_bib0014","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2021.103425_bib0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cei.13358","article-title":"Self-reported changes in the expanded disability status scale score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center","volume":"198","author":"Ruiz-Arguelles","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.msard.2021.103425_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102399","article-title":"Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica","volume":"45","author":"Ciotti","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.msard.2021.103425_bib0017","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2169\/internalmedicine.6153-20","article-title":"Aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder in a patient with charcot-marie-tooth disease type 1A","volume":"60","author":"Hamada","year":"2021","journal-title":"Intern. Med."},{"key":"10.1016\/j.msard.2021.103425_bib0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.103425_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.msard.2017.06.008","article-title":"Gender differences among Chinese patients with neuromyelitis optica spectrum disorders","volume":"17","author":"Sun","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2021.103425_bib0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.mayocp.2019.09.012","article-title":"Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis","volume":"95","author":"Nusbaum","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.msard.2021.103425_bib0021","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12883-014-0162-7","article-title":"Neuromyelitis optica spectrum disorders without and with autoimmune diseases","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.msard.2021.103425_bib0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3803\/EnM.2016.31.2.213","article-title":"Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease","volume":"31","author":"Wiersinga","year":"2016","journal-title":"Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.msard.2021.103425_bib0023","doi-asserted-by":"crossref","first-page":"fcz026","DOI":"10.1093\/braincomms\/fcz026","article-title":"Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study","volume":"1","author":"Chien","year":"2019","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.msard.2021.103425_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3899\/jrheum.160978","article-title":"Pediatric Neuromyelitis Optica Spectrum Disorder and Sj\u00f6gren Syndrome: More Common Than Previously Thought","volume":"44","author":"Gmuca","year":"2017","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.msard.2021.103425_bib0024","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41433-020-01334-8","article-title":"Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment","volume":"35","author":"Gospe","year":"2021","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.msard.2021.103425_bib0025","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4103\/0028-3886.294831","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody-associated CNS demyelination: clinical spectrum and comparison with aquaporin-4 antibody positive neuromyelitis optica spectrum disorder","volume":"68","author":"Ojha","year":"2020","journal-title":"Neurol. India"},{"issue":"2","key":"10.1016\/j.msard.2021.103425_bib0036","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.expneurol.2008.04.039","article-title":"Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination","volume":"212","author":"Franco","year":"2008","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.msard.2021.103425_bib0026","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/WCO.0000000000000828","article-title":"Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics","volume":"33","author":"Fujihara","year":"2020","journal-title":"Curr. Opin. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2021.103425_bib0027","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41374-020-0373-z","article-title":"TGFbeta1-smad canonical and -erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjogren's syndrome","volume":"100","author":"Sisto","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.msard.2021.103425_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.msard.2017.05.007","article-title":"Membranous nephropathy with Neuromyelitis optica spectrum disorder","volume":"15","author":"Li","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"10.1016\/j.msard.2021.103425_bib0028","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/labinvest.2011.190","article-title":"Sjogren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE\/NF-kappaB","volume":"92","author":"Lisi","year":"2012","journal-title":"Lab. Investig."},{"issue":"1-2","key":"10.1016\/j.msard.2021.103425_bib0029","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000358218","article-title":"Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis","volume":"72","author":"Wu","year":"2014","journal-title":"Eur. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2021.103425_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.beem.2004.11.004","article-title":"Non-thyroid autoantibodies in autoimmune thyroid disease","volume":"19","author":"Weetman","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.msard.2021.103425_bib0031","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00415-013-6997-9","article-title":"Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies","volume":"260","author":"Iorio","year":"2013","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2021.103425_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100672","article-title":"Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases","volume":"9","author":"Long","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.msard.2021.103425_bib0033","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-014-7298-7","article-title":"Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions","volume":"261","author":"Wang","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.103425_bib0034","series-title":"EDSS (Kurtzke Expanded Disability Status Score)","first-page":"1031","author":"Binder","year":"2009"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100691X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100691X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T16:36:55Z","timestamp":1735576615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482100691X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"alternative-id":["S221103482100691X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103425","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103425"}}